BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34607327)

  • 1. Gene Polymorphisms of Interleukin-27 Correlate with the Susceptibility, Severity, and Clinical Outcomes of Elderly People with Guillain-Barré Syndrome.
    Zhang H; Zhao H; Yang G; Li Y; Liu Y
    Gerontology; 2022; 68(8):854-860. PubMed ID: 34607327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-27 gene variant rs153109 is associated with enhanced cytokine serum levels and susceptibility to Behçet's disease in the Iranian population.
    Gholijani N; Daryabor G; Kalantar K; Yazdani MR; Shenavandeh S; Zahed M; Jafarpour Z; Malekmakan MR; Amirghofran Z
    Eur Cytokine Netw; 2020 Dec; 31(4):140-146. PubMed ID: 33648922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barré syndrome.
    Hayat S; Asad A; Hasan I; Jahan I; Papri N; Howlader ZH; Islam Z
    Acta Neurol Scand; 2022 Aug; 146(2):177-185. PubMed ID: 35652365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 promoter polymorphisms and haplotypes in patients with Guillain-Barré syndrome.
    Hayat S; Asad A; Munni MA; Nayeem MAJ; Mostafa MG; Jahan I; Howlader MZH; Mohammad QD; Islam Z
    Ann Clin Transl Neurol; 2024 Jan; 11(1):133-142. PubMed ID: 37955408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome.
    Islam Z; Jahan I; Ahammad RU; Shahnaij M; Nahar S; Mohammad QD
    PLoS One; 2018; 13(2):e0192703. PubMed ID: 29432441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor-4 299Gly allele is associated with Guillain-Barré syndrome in Bangladesh.
    Jahan I; Ahammad RU; Khalid MM; Rahman MI; Hayat S; Islam B; Mohammad QD; Islam Z
    Ann Clin Transl Neurol; 2019 Apr; 6(4):708-715. PubMed ID: 31019995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barré syndrome.
    Kharwar NK; Prasad KN; Singh K; Paliwal VK; Modi DR
    Int J Neurosci; 2017 Aug; 127(8):680-687. PubMed ID: 27595159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of IL-27 rs153109 and rs17855750 Polymorphisms with Risk and Response to Therapy in Acute Lymphoblastic Leukemia.
    Ghavami A; Fathpour G; Amirghofran Z
    Pathol Oncol Res; 2018 Jul; 24(3):653-662. PubMed ID: 28828696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of altered IL-33/ST2 immune axis in the immunobiology of Guillain-Barré syndrome.
    Sharma PP; Seshagiri DV; Nagappa M; Mullapudi T; Sreenivas N; Dey S; Shivaram S; Wahatule R; Kumawat V; Sreekumaran Nair BV; Kamath S; Sinha S; Taly AB; Debnath M
    Eur J Neurol; 2022 Jul; 29(7):2074-2083. PubMed ID: 35322935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
    St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
    J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc-gamma IIIa-V158F receptor polymorphism contributes to the severity of Guillain-Barré syndrome.
    Hayat S; Babu G; Das A; Howlader ZH; Mahmud I; Islam Z
    Ann Clin Transl Neurol; 2020 Jun; 7(6):1040-1049. PubMed ID: 32484314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen-DQB1 polymorphisms and haplotype patterns in Guillain-Barré syndrome.
    Hayat S; Jahan I; Das A; Hassan Z; Howlader ZH; Mahmud I; Deen Mohammad Q; Islam Z
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1849-1857. PubMed ID: 31469245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between FCGR2A and FCGR3A polymorphisms in Guillain-Barré Syndrome in a Brazilian population.
    Dourado ME; Ferreira LC; Freire-Neto FP; Jeronimo SM
    J Neuroimmunol; 2016 Sep; 298():160-4. PubMed ID: 27609290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.
    Zhou B; Zhang P; Tang T; Liao H; Zhang K; Pu Y; Chen P; Song Y; Zhang L
    BMC Cancer; 2015 May; 15():433. PubMed ID: 26014498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha -863C/A polymorphism is associated with Guillain-Barré syndrome in Bangladesh.
    Jahan I; Ahammad RU; Farzana KS; Khalid MM; Islam MB; Rahman MI; Nahar S; Kabir Y; Mohmmad QD; Islam Z
    J Neuroimmunol; 2017 Sep; 310():46-50. PubMed ID: 28778444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of matrix metalloproteinase-9 polymorphism with severity of Guillain-Barré syndrome.
    Hayat S; Ahmad O; Mahmud I; Howlader MZH; Islam Z
    J Neurol Sci; 2020 Aug; 415():116908. PubMed ID: 32447054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.
    Das A; Khurshid S; Hayat S; Ahmed R; Islam Z
    J Neuroimmunol; 2020 Nov; 348():577388. PubMed ID: 32949992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barre syndrome outbreak in Peru: Association with polymorphisms in IL-17, ICAM1, and CD1.
    Jaramillo-Valverde L; Levano KS; Villanueva I; Hidalgo M; Cornejo M; Mazzetti P; Cornejo-Olivas M; Sanchez C; Poterico JA; Valdivia-Silva J; Guio H
    Mol Genet Genomic Med; 2019 Oct; 7(10):e00960. PubMed ID: 31464097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barré Syndrome.
    Peng J; Zhang H; Liu P; Chen M; Xue B; Wang R; Shou J; Qian J; Zhao Z; Xing Y; Liu H
    Sci Rep; 2018 Feb; 8(1):2824. PubMed ID: 29434217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of mannose-binding lectin 2 gene polymorphisms with Guillain-Barré syndrome.
    Jahan I; Hayat S; Khalid MM; Ahammad RU; Asad A; Islam B; Mohammad QD; Jacobs BC; Islam Z
    Sci Rep; 2022 Apr; 12(1):5791. PubMed ID: 35388043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.